Perfil glicêmico e lipídico em meninos de diferentes classes sociais

Estudos sugerem que o nível socioeconômico (NSE) exerce influência no distúrbio metabólico, desta forma o presente estudo visou verificar as diferenças do perfil glicêmico e lipídico em meninos de diferentes classes sociais da cidade de Curitiba, Paraná. A amostra constituiu-se de 123 meninos (14,0±2,2 anos) sendo avaliado o perfil antropométrico, NSE, perfil glicêmico e lipídico. A análise estatística foi descritiva e para verificar as diferenças entre os níveis foi utilizado a ANOVA one-way com post hoc de Bonferroni com p< 0,05. Meninos de médio e alto NSE apresentaram maiores valores médios de glicemia em jejum, triglicerídeos (TG) e LDL-c do que indivíduos de baixo NSE (

Cutoff for body mass index in adolescents: comparison with national and international reference standards

OBJETIVO: elaborar uma tabela percentílica para o índice de massa corporal (IMC) para adolescentes na faixa etária de 10 a 14 anos da cidade de Curitiba, Paraná, e comparar os valores encontrados para o sobrepeso (percentil 85) e obesidade (percentil 95) com referências de IMC nacional, regional e internacional. MÉTODO: estudo longitudinal misto com 5231 avaliações, 2471 em meninos e 2760 em meninas, idades entre 10 e 14 anos. Esse número foi obtido a partir de avaliações semestrais realizadas entre os anos de 1998 a 2002, gerando 4321 observações (estudo longitudinal), mais a avaliação de 910 indivíduos no ano de 2006 (estudo transversal). O IMC foi calculado pela razão entre a massa corporal (Kg) dividida pela estatura (m) ao quadrado. Foram elaboradas tabelas de frequência baseadas na distribuição percentílica. Para identificar as diferenças nos pontos de corte para sobrepeso e obesidade com os estudos nacionais de Cintra e de Conde e Monteiro e com o estudo internacional de Cole foi utilizado teste binomial não paramétrico. RESULTADOS: comparando com as referências, os jovens de Curitiba seriam superestimados com sobrepeso se utilizadas a referência de Conde e a de Cole e subestimados na referência regional de Cintra. As mesmas tendências foram observadas com relação ao percentil 95 (obesidade), porém não para todas as faixas etárias. CONCLUSÃO: observamos diferenças nos valores de IMC sugeridos como pontos de corte para sobrepeso e obesidade em relação às referências nacionais e internacionais reforçando a necessidade de utilização de referências específicas para cada população.OBJECTIVE: to develop a scale percentile for body mass index (BMI) for adolescents aged 10 to 14 years from the city of Curitiba, Paraná, and compare the values found for overweight (85th percentile) and obesity (95th percentile) with references to national and international BMI. METHOD: mixed longitudinal study with 5231 evaluation, 2471 in boys and girls in 2760, aged 10 and 14 years. This number was obtained from semester evaluations conducted between the years 1998 to 2002, generating 4321 observations (longitudinal study), further evaluation of 910 individuals in 2006 (cross-sectional study). BMI was calculated as the ratio of body mass (kg) divided by height (m) squared. Frequency tables were prepared based on the percentile distribution. To identify differences in cut-off points for overweight and obesity with the national study of Cintra, and Conde and with the international study of Cole non-parametric binomial test was used. RESULTS: compared with the references, the young people of Curitiba were overestimated overweight if used for the reference of Conde and Cole and underestimated in the regional reference Cintra. The same trends were observed with respect to the 95th percentile (obesity), but not for all ages. CONCLUSION: we observed differences in the values of BMI suggested as cut-off points for overweight and obesity in relation to national and international references emphasizing the need to use specific references for each population

International Consensus Guideline on Small for Gestational Age (SGA): Etiology and Management from Infancy to Early Adulthood

: This International Consensus Guideline was developed by experts in the field of SGA of 10 pediatric endocrine societies worldwide. A consensus meeting was held and 1300 articles formed the basis for discussions. All experts voted about the strengths of the recommendations. The guideline gives new and clinically relevant insights into the etiology of short stature after SGA birth, including novel knowledge about (epi)genetic causes. Besides, it presents long-term consequences of SGA birth and new treatment options, including treatment with gonadotropin-releasing hormone agonist (GnRHa) in addition to growth hormone (GH) treatment, and the metabolic and cardiovascular health of young adults born SGA after cessation of childhood-GH-treatment in comparison with appropriate control groups. To diagnose SGA, accurate anthropometry and use of national growth charts are recommended. Follow-up in early life is warranted and neurodevelopment evaluation in those at risk. Excessive postnatal weight gain should be avoided, as this is associated with an unfavorable cardio-metabolic health profile in adulthood. Children born SGA with persistent short stature &lt; -2.5 SDS at age 2 years or &lt; -2 SDS at age of 3-4 years, should be referred for diagnostic work-up. In case of dysmorphic features, major malformations, microcephaly, developmental delay, intellectual disability and/or signs of skeletal dysplasia, genetic testing should be considered. Treatment with 0.033-0.067 mg GH/kg/day is recommended in case of persistent short stature at age of 3-4 years. Adding GnRHa treatment could be considered when short adult height is expected at pubertal onset. All young adults born SGA require counseling to adopt a healthy lifestyle

Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement

Growth hormone (GH) has been used for over 35 years, and its safety and efficacy has been studied extensively. Experimental studies showing the permissive role of GH/insulin-like growth factor 1 (IGF-I) in carcinogenesis have raised concerns regarding the safety of GH replacement in children and adults who have received treatment for cancer and those with intracranial and pituitary tumours. A consensus statement was produced to guide decision-making on GH replacement in children and adult survivors of cancer, in those treated for intracranial and pituitary tumours and in patients with increased cancer risk. With the support of the European Society of Endocrinology, the Growth Hormone Research Society convened a Workshop, where 55 international key opinion leaders representing 10 professional societies were invited to participate. This consensus statement utilized: (1) a critical review paper produced before the Workshop, (2) five plenary talks, (3) evidence-based comments from four breakout groups, and (4) discussions during report-back sessions. Current evidence reviewed from the proceedings from the Workshop does not support an association between GH replacement and primary tumour or cancer recurrence. The effect of GH replacement on secondary neoplasia risk is minor compared to host- and tumour treatment-related factors. There is no evidence for an association between GH replacement and increased mortality from cancer amongst GH-deficient childhood cancer survivors. Patients with pituitary tumour or craniopharyngioma remnants receiving GH replacement do not need to be treated or monitored differently than those not receiving GH. GH replacement might be considered in GH-deficient adult cancer survivors in remission after careful individual risk/benefit analysis. In children with cancer predisposition syndromes, GH treatment is generally contraindicated but may be considered cautiously in select patients

Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations

Objective The Growth Hormone (GH) Research Society (GRS) convened a workshop to address important issues regarding trial design, efficacy, and safety of long-acting growth hormone preparations (LAGH). Participants A closed meeting of 55 international scientists with expertise in GH, including pediatric and adult endocrinologists, basic scientists, regulatory scientists, and participants from the pharmaceutical industry. Evidence Current literature was reviewed for gaps in knowledge. Expert opinion was used to suggest studies required to address potential safety and efficacy issues. Consensus process Following plenary presentations summarizing the literature, breakout groups discussed questions framed by the planning committee. Attendees reconvened after each breakout session to share group reports. A writing team compiled the breakout session reports into a draft document that was discussed and revised in an open forum on the concluding day. This was edited further and then circulated to attendees from academic institutions for review after the meeting. Participants from pharmaceutical companies did not participate in the planning, writing, or in the discussions and text revision on the final day of the workshop. Scientists from industry and regulatory agencies reviewed the manuscript to identify any factual errors. Conclusions LAGH compounds may represent an advance over daily GH injections because of increased convenience and differing phamacodynamic properties, providing the potential for improved adherence and outcomes. Better methods to assess adherence must be developed and validated. Long-term surveillance registries that include assessment of efficacy, cost-benefit, disease burden, quality of life, and safety are essential for understanding the impact of sustained exposure to LAGH preparations

Physical activity, cardiorespiratory fitness, and metabolic syndrome in adolescents: A cross-sectional study

<p>Abstract</p> <p>Background</p> <p>In adults, there is a substantial body of evidence that physical inactivity or low cardiorespiratory fitness levels are strongly associated with the development of metabolic syndrome. Although this association has been studied extensively in adults, little is known regarding this association in adolescents. The aim of this study was to analyze the association between physical activity and cardiorespiratory fitness levels with metabolic syndrome in Brazilian adolescents.</p> <p>Methods</p> <p>A random sample of 223 girls (mean age, 14.4 ± 1.6 years) and 233 boys (mean age, 14.6 ± 1.6 years) was selected for the study. The level of physical activity was determined by the Bouchard three-day physical activity record. Cardiorespiratory fitness was estimated by the Leger 20-meter shuttle run test. The metabolic syndrome components assessed included waist circumference, blood pressure, HDL-cholesterol, triglycerides, and fasting plasma glucose levels. Independent Student <it>t</it>-tests were used to assess gender differences. The associations between physical activity and cardiorespiratory fitness with the presence of metabolic syndrome were calculated using logistic regression models adjusted for age and gender.</p> <p>Results</p> <p>A high prevalence of metabolic syndrome was observed in inactive adolescents (males, 11.4%; females, 7.2%) and adolescents with low cardiorespiratory fitness levels (males, 13.9%; females, 8.6%). A significant relationship existed between metabolic syndrome and low cardiorespiratory fitness (OR, 3.0 [1.13-7.94]).</p> <p>Conclusion</p> <p>The prevalence of metabolic syndrome is high among adolescents who are inactive and those with low cardiorespiratory fitness. Prevention strategies for metabolic syndrome should concentrate on enhancing fitness levels early in life.</p

Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations: Table 1

The Growth Hormone (GH) Research Society (GRS) convened a workshop to address important issues regarding trial design, efficacy, and safety of long-acting growth hormone preparations (LAGH)

Potential Effects of Oral Isotretinoin on Growth Plate and Height

Longitudinal growth and puberty are the result of a complex interaction of genetic, hormonal, nutritional, and environmental factors. Acne vulgaris is a chronic disease of the pilosebaceous unit that affects 85% of adolescents worldwide. Isotretinoin is a synthetic vitamin A derivative drug effective and is widely employed for the treatment of moderate and severe acne vulgaris. Premature epiphyseal closure has been reported in patients with neuroblastoma treated with high doses of isotretinoin as well as in patients with acne receiving lower doses. Although the mechanisms for these effects are not clear, it has been suggested that isotretinoin may have a negative impact on the GH-IGF-I axis, leading to a reduction in IGF-I and IGFBP3 serum levels. Although many of the isotretinoin adverse effects in pediatric patients are transient, premature epiphyseal closure and bone abnormalities can lead to transient abnormalities and permanent deformities with a negative impact on longitudinal growth and final height. The aim of this study was to review the potential effects of oral isotretinoin on the growth plate and growth during childhood and adolescence

Atividade física na criança com diabetes tipo 1

OBJETIVO: Abordar os aspectos práticos da realização segura de atividade física e esportes em crianças e adolescentes portadores de diabetes tipo 1. FONTES DOS DADOS: A pesquisa dos artigos foi conduzida em fontes de dados nacionais (SciELO) e internacionais (PubMed/MEDLINE), assim como nas próprias referências dos artigos encontrados, adotando como limites: artigos publicados nos últimos 10 anos, preferencialmente conduzidos em crianças e adolescentes com diabetes tipo 1, sendo em sua maioria estudos experimentais e meta-análises sobre atividade física. SÍNTESE DOS DADOS: Com o metabolismo aeróbico, os músculos esqueléticos consomem maior quantidade de glicose para gerar energia, o que diminui a gliconeogênese hepática, levando a uma diminuição na glicemia e aumentando o risco de hipoglicemia. A reposição de carboidratos antes, durante e após o exercício em quantidade adequada e a redução da dose de insulina de ação rápida (pré-refeição) são os principais aliados da criança e adolescente com diabetes tipo 1 para evitar a ocorrência da hipoglicemia severa. CONCLUSÕES: Para a reposição de carboidratos e a redução da dose de insulina, deve-se considerar o tipo, a duração e a intensidade da atividade física, bem como o horário de sua realização. A participação em diversos esportes, coletivos e individuais, e em atividades físicas de intensidades variadas é possível, sendo muito recomendado no tratamento do diabetes infantil